Kolexia
Morel Florence
Biologie médicale
Lbm Guevalt Site Henri Iv
Paris, France
34 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tuberculose Tuberculose multirésistante Diabète de type 2 Tuberculose pulmonaire Artériopathies oblitérantes Tuberculose ultrarésistante aux médicaments Neuropathies diabétiques Entorses et foulures Infections à Mycoplasma

Industries

MSD
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
The Lancet. Infectious diseases   28 février 2023
How a PCR Sequencing Strategy Can Bring New Data to Improve the Diagnosis of Ethionamide Resistance.
Microorganisms   15 juillet 2022
atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure.
Emerging infectious diseases   25 avril 2022
A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Complex Directly From Clinical Samples.
Frontiers in cellular and infection microbiology   29 octobre 2021
Impact of the revised definition of extensively drug-resistant tuberculosis.
The European respiratory journal   19 août 2021
Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological Malignancy.
Frontiers in immunology   03 août 2021
A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   13 juillet 2021
Rapid Molecular Diagnosis of Tuberculosis and Its Resistance to Rifampicin and Isoniazid with Automated MDR/MTB ELITe MGB Assay.
Antibiotics (Basel, Switzerland)   30 juin 2021
Genomic characterization of 16S rRNA methyltransferase-producing Escherichia coli isolates from the Parisian area, France.
The Journal of antimicrobial chemotherapy   24 juin 2021
Sampling strategy for bacteriological diagnosis of intrathoracic tuberculosis.
Respiratory medicine and research   27 avril 2021